相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
Phuong H. D. Nguyen et al.
NATURE COMMUNICATIONS (2021)
Tumor-Infiltrating Natural Killer Cells
Beatriz Cozar et al.
CANCER DISCOVERY (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Natural killers or ILC1s? That is the question
Cyril Seillet et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
Alessandra Zecca et al.
CELLS (2021)
Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10
Yumi Otoyama et al.
ANTICANCER RESEARCH (2021)
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
Jennifer A. Foltz et al.
CLINICAL CANCER RESEARCH (2021)
Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop
Lu Bai et al.
SCIENCE (2021)
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade
Amber G. Bozward et al.
FRONTIERS IN IMMUNOLOGY (2021)
Insights Into Human Intrahepatic NK Cell Function From Single Cell RNA Sequencing Datasets
Grainne Jameson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments
Olivier Demaria et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis
Laura Ducimetiere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Faroogh Marofi et al.
FRONTIERS IN ONCOLOGY (2021)
Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors
Pauline Rettman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity
Valery L. Payen et al.
JHEP REPORTS (2021)
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells
J. M. R. Van der Meer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma
Hui Li et al.
AGING-US (2020)
Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles
Mei Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma
Qiu-Zhong Pan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
Ann-Lii Cheng et al.
JOURNAL OF HEPATOLOGY (2020)
Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitis
Lorenzo A. Orci et al.
LIVER INTERNATIONAL (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Tumor intrinsic and extrinsic immune functions of CD155
Jake. S. O'Donnell et al.
SEMINARS IN CANCER BIOLOGY (2020)
The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Haiyu Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma
L. Tao et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
The liver as an immunological barrier redefined by single-cell analysis
Zania Stamataki et al.
IMMUNOLOGY (2020)
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2020)
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10
Cristina Bergamaschi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human
Juanjuan Zhao et al.
CELL DISCOVERY (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes
Di Cao et al.
AGING-US (2020)
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Nancy L. Bartlett et al.
BLOOD (2020)
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
Melanie Desbois et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome
Nicholas J. W. Easom et al.
FRONTIERS IN ONCOLOGY (2020)
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang et al.
JOURNAL OF HEPATOLOGY (2020)
Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity
Julia A. Wagner et al.
CELL REPORTS (2020)
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
Susanna S. Ng et al.
NATURE IMMUNOLOGY (2020)
Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
Hsiang-chi Tseng et al.
NATURE COMMUNICATIONS (2020)
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
Simona Sivori et al.
FRONTIERS IN IMMUNOLOGY (2020)
A single cell atlas of the human liver tumor microenvironment
Hassan Massalha et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
Sri Krishna et al.
SCIENCE (2020)
Single-cell omics analysis reveals functional diversification of hepatocytes during liver regeneration
Tianyi Chen et al.
JCI INSIGHT (2020)
Natural killer cell engineering - a new hope for cancer immunotherapy
Cheng-Yu Lin et al.
SEMINARS IN HEMATOLOGY (2020)
Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity
Qizhi Luo et al.
AGING AND DISEASE (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
Jeong-Hoon Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
Stefania Mantovani et al.
HEPATOLOGY (2019)
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
Linh T. Nguyen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Sensing of physiological regulators by innate lymphoid cells
Cyril Seillet et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells
Shin Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy
Beatriz Sanchez-Correa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Takahiro Kamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma
Sandrine Faivre et al.
LIVER INTERNATIONAL (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hide and seek: Plasticity of innate lymphoid cells in cancer
Tobias Bald et al.
SEMINARS IN IMMUNOLOGY (2019)
Turning the Tide Against Regulatory T Cells
SeongJun Han et al.
FRONTIERS IN ONCOLOGY (2019)
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck
Ashley Pinette et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications
Elisabetta Cariani et al.
LIVER INTERNATIONAL (2019)
Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy
Xiaojie Yu et al.
MABS (2019)
Development of c-MET-specific chimeric antigen receptor-engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells
Bing Liu et al.
MOLECULAR MEDICINE REPORTS (2019)
A human liver cell atlas reveals heterogeneity and epithelial progenitors
Nadim Aizarani et al.
NATURE (2019)
Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma
Haoyu Sun et al.
CANCER IMMUNOLOGY RESEARCH (2019)
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
R. K. Kelley et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
The Natural Cytotoxicity Receptors in Health and Disease
Alexander David Barrow et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology
Joanna Mikulak et al.
FRONTIERS IN IMMUNOLOGY (2019)
Liver-Derived TGF-β Maintains the EomeshiTbetlo Phenotype of Liver Resident Natural Killer Cells
Cathal Harmon et al.
FRONTIERS IN IMMUNOLOGY (2019)
Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
Francesca Romana Merlotti et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Role of Myeloid-Derived Cells in the Progression of Liver Disease
Chris John Weston et al.
FRONTIERS IN IMMUNOLOGY (2019)
Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
Ziqing Chen et al.
CANCERS (2019)
Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice
Elena Burova et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Therapeutic blockade of activin-A improves NK cell function and antitumor immunity
Jai Rautela et al.
SCIENCE SIGNALING (2019)
The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review
Sarun Juengpanich et al.
TRANSLATIONAL ONCOLOGY (2019)
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U. Dafni et al.
ANNALS OF ONCOLOGY (2019)
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
Bettina Langhans et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
P. Ramachandran et al.
NATURE (2019)
Harnessing innate immunity in cancer therapy
Olivier Demaria et al.
NATURE (2019)
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Xiaohu Zheng et al.
NATURE IMMUNOLOGY (2019)
Liver-Mediated Adaptive Immune Tolerance
Meijuan Zheng et al.
FRONTIERS IN IMMUNOLOGY (2019)
29-Color Flow Cytometry: Unraveling Human Liver NK Cell Repertoire Diversity
Iva Filipovic et al.
FRONTIERS IN IMMUNOLOGY (2019)
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Jiaqiang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
2B4 and CD48: A powerful couple of the immune system
Hadas Pahima et al.
CLINICAL IMMUNOLOGY (2019)
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
Haoyu Sun et al.
HEPATOLOGY (2019)
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma
Su Jong Yu et al.
JOURNAL OF HEPATOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimaraes et al.
TRENDS IN IMMUNOLOGY (2019)
Adoptive cell transfer therapy for hepatocellular carcinoma
Renyu Zhang et al.
FRONTIERS OF MEDICINE (2019)
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
Alexander D. Barrow et al.
CELL (2018)
Mouse models for the study of fate and function of innate lymphoid cells
Sascha Cording et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells
Jun Arai et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases
Gautam U. Mehta et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Min Yu et al.
MOLECULAR THERAPY (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
Activating and inhibitory receptors expressed on innate lymphoid cells
Sophie Guia et al.
SEMINARS IN IMMUNOPATHOLOGY (2018)
Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease
Lei Dou et al.
SEMINARS IN LIVER DISEASE (2018)
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
Kaku Goto et al.
Oncotarget (2018)
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies
Norbert Vey et al.
Oncotarget (2018)
The immune contexture of hepatocellular carcinoma predicts clinical outcome
Friedrich Foerster et al.
SCIENTIFIC REPORTS (2018)
IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
Nicholas J. W. Easom et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
Faezeh Hosseinzadeh et al.
CANCER CELL INTERNATIONAL (2018)
Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC
Haoyu Sun et al.
CANCER RESEARCH (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome
Mohammed Alnaggar et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier et al.
IMMUNITY (2018)
Deconstructing deployment of the innate immune lymphocyte army for barrier homeostasis and protection
Francisca F. Almeida et al.
IMMUNOLOGICAL REVIEWS (2018)
Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications
Pil Soo Sung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
Sonya A. MacParland et al.
NATURE COMMUNICATIONS (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
Cheng Sun et al.
ONCOIMMUNOLOGY (2017)
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
Laetitia Fend et al.
ONCOIMMUNOLOGY (2017)
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Sylvie Rusakiewicz et al.
ONCOIMMUNOLOGY (2017)
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
William C. Dougall et al.
IMMUNOLOGICAL REVIEWS (2017)
Cutting Edge: Human CD49e- NK Cells Are Tissue Resident in the Liver
Han Xian Aw Yeang et al.
JOURNAL OF IMMUNOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
Smita S. Chandran et al.
LANCET ONCOLOGY (2017)
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
Martina Molgora et al.
NATURE (2017)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
Keren Bahar Halpern et al.
NATURE (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
Valerie Chew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
Zachary B. Davis et al.
SEMINARS IN IMMUNOLOGY (2017)
The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma
Weiwei Zhai et al.
NATURE COMMUNICATIONS (2017)
Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer
Mao Lin et al.
ONCOTARGET (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Shaping Innate Lymphoid Cell Diversity
Qiutong Huang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Veronika Kremer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Innate lymphoid cells: major players in inflammatory diseases
Mikael Ebbo et al.
NATURE REVIEWS IMMUNOLOGY (2017)
T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation
Brandon Kwong et al.
NATURE IMMUNOLOGY (2017)
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling
Victor S. Cortez et al.
NATURE IMMUNOLOGY (2017)
Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers
Marianne Forkel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
Zhongjuan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Complement factor P is a ligand for the natural killer cell-activating receptor NKp46
Emilie Narni-Mancinelli et al.
SCIENCE IMMUNOLOGY (2017)
IL-15 signaling in NK cell cancer immunotherapy
Jai Rautela et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
Maximillian Rosario et al.
CLINICAL CANCER RESEARCH (2016)
Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
Dimitrios Mathios et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
Andrea Kristina Horst et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
SLAM family receptors in normal immunity and immune pathologies
Ning Wu et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells
Nicholas D. Huntington et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Tissue-resident Eomeshi T-betlo CD56bright NK cells with reduced proinflammatory potential are enriched in the adult human liver
Cathal Harmon et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands
Victor S. Cortez et al.
IMMUNITY (2016)
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
Kelly Hudspeth et al.
JOURNAL OF AUTOIMMUNITY (2016)
Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s
Ling Tang et al.
JOURNAL OF AUTOIMMUNITY (2016)
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
Bai Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis
Sharon Pok et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation
Antonia O. Cuff et al.
JOURNAL OF IMMUNOLOGY (2016)
Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage
Olga Pikovskaya et al.
JOURNAL OF IMMUNOLOGY (2016)
Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection
F. F. Almeida et al.
MUCOSAL IMMUNOLOGY (2016)
The evolution of innate lymphoid cells
Eric Vivier et al.
NATURE IMMUNOLOGY (2016)
Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes
Laura K. Mackay et al.
SCIENCE (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
Andrew Gabrielson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Type 1 innate Lymphoid Cell Biology: Lessons Learnt from Natural Killer Cells
Yuhao Jiao et al.
FRONTIERS IN IMMUNOLOGY (2016)
NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution
Meriem Messaoudene et al.
ONCOIMMUNOLOGY (2016)
CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
Kerstin A. Stegmann et al.
SCIENTIFIC REPORTS (2016)
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun et al.
ACTA PHARMACOLOGICA SINICA (2015)
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma
Achim Rothe et al.
BLOOD (2015)
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Don M. Benson et al.
CLINICAL CANCER RESEARCH (2015)
The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
Jeremy Dupaul-Chicoine et al.
IMMUNITY (2015)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type
Bettina Langhans et al.
JOURNAL OF HEPATOLOGY (2015)
IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ
Yin Guo et al.
JOURNAL OF IMMUNOLOGY (2015)
Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells
Nicole Marquardt et al.
JOURNAL OF IMMUNOLOGY (2015)
Tumor-infiltrating lymphocytes for the treatment of metastatic cancer
M. H. Geukes Foppen et al.
MOLECULAR ONCOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs
Georg Gasteiger et al.
SCIENCE (2015)
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients
Michaela Semeraro et al.
Science Translational Medicine (2015)
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
Maria Serova et al.
ONCOTARGET (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages
Christoph S. N. Klose et al.
CELL (2014)
Conditional ablation of NKp46+ cells using a novel Ncr1greenCre mouse strain: NK cells are essential for protection against pulmonary B16 metastases
Leila Ben Merzoug et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature
Lijuan Xiong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Xiaozhou Yu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma
Liang Fang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Nfil3 is required for the development of all innate lymphoid cell subsets
Cyril Seillet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow
Cecile Daussy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Differential Requirement for Nfil3 during NK Cell Development
Cyril Seillet et al.
JOURNAL OF IMMUNOLOGY (2014)
Cutting Edge: Salivary Gland NK Cells Develop Independently of Nfil3 in Steady-State
Victor S. Cortez et al.
JOURNAL OF IMMUNOLOGY (2014)
A committed precursor to innate lymphoid cells
Michael G. Constantinides et al.
NATURE (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
The CD94/NKG2C+NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection
Miguel Lopez-Botet et al.
SEMINARS IN IMMUNOLOGY (2014)
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
Priyanka Sathe et al.
NATURE COMMUNICATIONS (2014)
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
Dorothy K. Sojka et al.
ELIFE (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Andres Wiernik et al.
CLINICAL CANCER RESEARCH (2013)
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
Martin Franz Sprinzl et al.
HEPATOLOGY (2013)
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
Yan Wu et al.
HEPATOLOGY (2013)
Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12-and IL-15-Responsive IFN-γ-Producing Cells
Anja Fuchs et al.
IMMUNITY (2013)
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
Hui Peng et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Nfil3-independent lineage maintenance and antiviral response of natural killer cells
Matthew A. Firth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome
Sylvie Rusakiewicz et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
Shun-Jun Fu et al.
SURGERY (2013)
Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma
Jian-Jun Li et al.
CHINESE JOURNAL OF CANCER (2013)
Innate lymphoid cells - a proposal for uniform nomenclature
Hergen Spits et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma
Cun-Li Guo et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum
Cristina Bergamaschi et al.
BLOOD (2012)
Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma
Keisuke Kohga et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Tuanjie Li et al.
CANCER LETTERS (2012)
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
Ariane Thielens et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew et al.
GUT (2012)
Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma
N. E. El-Bassiouni et al.
MOLECULAR BIOLOGY REPORTS (2012)
Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
Vinod Kumar et al.
PLOS ONE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development
Eva Eckelhart et al.
BLOOD (2011)
Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor
Emilie Narni-Mancinelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
Intrahepatic IL-10 Maintains NKG2A+Ly49- Liver NK Cells in a Functionally Hyporesponsive State
Matthew G. Lassen et al.
JOURNAL OF IMMUNOLOGY (2010)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
Maturation of mouse NK cells is a 4-stage developmental program
Laura Chiossone et al.
BLOOD (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo
Shintaro Kamizono et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
Duncan M. Gascoyne et al.
NATURE IMMUNOLOGY (2009)
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
Lun Cai et al.
CLINICAL IMMUNOLOGY (2008)
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
Qiang You et al.
HEPATOLOGY (2008)
TLR-dependent cross talk between human Kupffer cells and NK cells
Zhengkun Tu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Liver: An organ with predominant innate immunity
Bin Gao et al.
HEPATOLOGY (2008)
CD56bright CD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation
Chiara Romagnani et al.
JOURNAL OF IMMUNOLOGY (2007)
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo
EP von Strandmann et al.
BLOOD (2006)
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2006)
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas
M Jinushi et al.
JOURNAL OF HEPATOLOGY (2005)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver
K Takeda et al.
BLOOD (2005)
Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor α expression
KS Schluns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Possible contribution of circulating transforming growth factor-β1 to immunity and prognosis in unresectable hepatocellular carcinoma
K Okumoto et al.
LIVER INTERNATIONAL (2004)
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic
G Ferlazzo et al.
JOURNAL OF IMMUNOLOGY (2004)
Coordinate expression and trans presentation of interleukin (IL)-15Rα and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis
PR Burkett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2:: a potential new link between adaptive and innate immunity
TA Fehniger et al.
BLOOD (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
In vivo developmental stages in murine natural killer cell maturation
S Kim et al.
NATURE IMMUNOLOGY (2002)
Roles of TGF-beta in hepatic fibrosis
AM Gressner et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
分享论文
